Abortion

Majorities Oppose State Laws Criminalizing Abortion, Even Those Living In States Where Abortion Will Become Illegal If Roe Is Overturned Misconceptions Around Abortions Persist With Most Women of Reproductive Age Unaware Of Medication Abortion And Many Confusing It With Emergency Contraception More than a third (37%) of voters say that…

This poll analyses the general public’s understanding of abortion access and reproductive health following a leaked draft of the U.S Supreme Court opinion on Dobbs v. Jackson Women’s Health Center. The poll also looks at how the aftermath of the leaked opinion may affect voting in the upcoming midterm election. This KFF poll also finds that there are significant knowledge gaps on the prevalence and the overall safety of abortions.

On June 9, KFF released findings from a national public opinion survey on abortion. The event highlighted key issues including awareness and attitudes of the impending Supreme Court opinion, its potential impact on abortion access, the importance of abortion policy to voting preferences in this year’s midterm elections, and knowledge of abortion and related health care.

If the Supreme Court overturns Roe v. Wade, states will set their own abortion policies without any federal constitutional standards. Access to abortion care will be protected in 16 states and DC, while abortion will likely become illegal for 18 states.

Many states impose a jail sentence for doctors who perform abortions past state established gestational limit. Here’s the breakdown of the jail time and state established gestational limits in effect as of May 2022.

This policy watch explains the April 21, 2023 United States Supreme Court’s ruling on Alliance for Hippocratic Medicine v. FDA, a case challening the FDA’s approval of mifepristone, the medication abortion pill.

This policy watch explains the two conflicting rulings on the provision of mifepristone issued by two separate District Courts on April 7, 2023, Alliance for Hippocratic Medicine v. FDA and State of Washington v. United States Food and Drug Administration.

In anticipation of a ruling in a case with enormous implications for access to medication abortion in the United States, a new KFF brief explains the impact of this case, and others filed in federal courts, involving the FDA’s regulation of medication abortion. The case that has gotten the most…

This issue brief details the Alliance of Hippocratic Medicine challenge to the FDA’s approval of the abortion pill, mifepristone. It provides context for the challenge, as well as what some of the possible rulings in the case could mean for access to medication abortion.

Access to medication abortion has emerged as a central issue following the Dobbs decision overturning Roe v. Wade. There is ongoing litigation in four federal cases about the FDA’s approval and regulation of mifepristone, one of the two drugs used in medication abortion. Mifepristone, approved by the FDA in 2000,…